their
Tuesday, December 17, 2024
Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.
Tuesday, December 17, 2024
"Generic drug"
VENUS REMEDIES BAGS APPROVAL TO MARKET MEROPENEM, ITS BLOCKBUSTER GENERIC DRUG, IN SPAIN
Thursday, June 22, 2023
Usfda
Saturday, February 01, 2025
Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules
Saturday, February 01, 2025
Guidelines for Opening of Jan Aushadhi Store
Thursday, December 29, 2016
